Exploring relationships between first-line nurse manager's safety attitudes and safety factors in Henan, China

被引:9
|
作者
Zhang, Feng [1 ]
Tian, Li [2 ]
Shang, Xiaoping [3 ]
Li, Xiang [2 ]
Xue, Rui [2 ]
Cheng, Shuhua [1 ]
Chen, Changying [4 ]
机构
[1] Zhengzhou Univ, Dept Rheumatol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[3] Zhengzhou Univ, Dept Med Record, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[4] Zhengzhou Univ, Affiliated Hosp 1, Coll Nursing, Zhengzhou, Henan, Peoples R China
关键词
Chinese hospital; first-line nurse manager; nursing; safety attitudes questionnaire; safety culture; INTENSIVE-CARE-UNIT; EDUCATIONAL-LEVELS; PATIENT MORTALITY; CULTURE; LEADERSHIP; OUTCOMES; PERCEPTIONS; HOSPITALS;
D O I
10.1111/jonm.12549
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
Aim: To examine first-line nurse managers' perceptions of safety culture and explore relationships between their safety attitudes and safety factors in Henan Province, China. Background: Health providers' perceptions of patient safety culture have been studied widely, but little is known about first-line nurse managers' safety attitudes. Methods: A cross-sectional survey was conducted with a convenience sample of 823 first-line nurse managers in 216 hospitals across Henan Province, China. The Safety Attitudes Questionnaire (Chinese version) was distributed to first-line nurse managers during training meetings; responses were returned in a sealed envelope in person or by mail. ANOVAs were used to analyse the differences in Safety Attitudes Questionnaire (Chinese version) scores between first-line nurse managers' attitudes and safety factors. Results: The mean scores across the six domains of Safety Attitudes Questionnaire (Chinese version) ranged from 56.6 to 79.4 on a 100-point scale. First-line nurse managers: 45years of age perceived better safety climate (p<.05); those with higher professional ranks and medical centre positions reported higher mean scores for teamwork climate (p<.01) and stress recognition (p<.01); and those with baccalaureate degrees or higher had significantly higher mean scores for stress recognition (p<.01). Conclusion: First-line nurse managers' safety attitudes were not satisfactory and there is great potential to improve patient safety culture. Age, hospital level, educational background and professional rank are positively related to first-line nurse managers' attitudes.
引用
收藏
页码:314 / 320
页数:7
相关论文
共 50 条
  • [21] First-Line Sofia Aspiration Thrombectomy Approach within the Endovascular Treatment of Ischemic Stroke Multicentric Registry: Efficacy, Safety, and Predictive Factors of Success
    Marnat, G.
    Barreau, X.
    Detraz, L.
    Bourcier, R.
    Gory, B.
    Sgreccia, A.
    Gariel, F.
    Berge, J.
    Menegon, P.
    Kyheng, M.
    Labreuche, J.
    Consoli, A.
    Blanc, R.
    Lapergue, B.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2019, 40 (06) : 1006 - 1012
  • [22] SAFETY AND EFFICACY OF ALBUMIN-BOUND PACLITAXEL AND OXALIPLATIN AND S-1 AS FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED GASTRIC CANCER
    Lou, H.
    Pan, H.
    Pan, Q.
    Li, D.
    Jin, W.
    ANNALS OF ONCOLOGY, 2012, 23 : 256 - 256
  • [23] A meta-analysis of efficacy and safety of S-1 monotherapy or combination therapy as first-line treatment in metastatic colorectal cancer
    Wang, Zhan
    Wang, Miao-Miao
    Zhou, Wen-Li
    Ye, Chen-Yang
    Dai, Wei-Ping
    Liu, Xin-Ling
    Zhang, Gui-Min
    Cheng, Guo-Liang
    Zang, Yuan-Sheng
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020, 35 (08) : 1567 - 1574
  • [24] A meta-analysis of efficacy and safety of S-1 monotherapy or combination therapy as first-line treatment in metastatic colorectal cancer
    Zhan Wang
    Miao-Miao Wang
    Wen-Li Zhou
    Chen-Yang Ye
    Wei-Ping Dai
    Xin-Ling Liu
    Gui-Min Zhang
    Guo-Liang Cheng
    Yuan-Sheng Zang
    International Journal of Colorectal Disease, 2020, 35 : 1567 - 1574
  • [25] Efficacy and safety comparison of nabpaclitaxel plus S-1 and gemcitabine plus S-1 as first-line chemotherapy for metastatic pancreatic cancer
    Xu, Yaolin
    Guo, Xi
    Fan, Yue
    Wang, Dansong
    Wu, Wenchuan
    Wu, Lili
    Liu, Tianshu
    Xu, Bei
    Feng, Yi
    Wang, Yan
    Lou, Wenhui
    Zhou, Yuhong
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (06) : 535 - 541
  • [26] COMPARISON EFFICACY AND SAFETY BETWEEN ATEZOLIZUMAB PLUS BEVACIZUMAB AND LENVATINIB AS FIRST-LINE SYSTEMIC THERAPY FOR HEPATOCELLULAR CARCINOMA: A REAL-WORLD STUDY
    Boonkaya, Sangdao
    Thanapirom, Kessarin
    Siripon, Nipaporn
    Thaimai, Panarat
    Ananchuensook, Prooksa
    Sriphoosanaphan, Supachaya
    Tanasanvimon, Surbpong
    Treeprasertsuk, Sombat
    Komolmit, Piyawat
    GASTROENTEROLOGY, 2024, 166 (05) : S73 - S74
  • [27] Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China
    Minmin Zhao
    Shanhu Qiu
    Xin Wu
    Pengcheng Miao
    Zhi Jiang
    Tao Zhu
    Xizhong Xu
    Yanling Zhu
    Bei Zhang
    Donglan Yuan
    Yang Zhang
    Wei Sun
    Aiqin He
    Min Zhao
    Wenjie Hou
    Yingli Zhang
    Zhuyan Shao
    Meiqun Jia
    Mei Li
    Jun Chen
    Jingcheng Xu
    Bingwei Chen
    Ying Zhou
    Yang Shen
    Targeted Oncology, 2023, 18 : 869 - 883
  • [28] Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China
    Zhao, Minmin
    Qiu, Shanhu
    Wu, Xin
    Miao, Pengcheng
    Jiang, Zhi
    Zhu, Tao
    Xu, Xizhong
    Zhu, Yanling
    Zhang, Bei
    Yuan, Donglan
    Zhang, Yang
    Sun, Wei
    He, Aiqin
    Zhao, Min
    Hou, Wenjie
    Zhang, Yingli
    Shao, Zhuyan
    Jia, Meiqun
    Li, Mei
    Chen, Jun
    Xu, Jingcheng
    Chen, Bingwei
    Zhou, Ying
    Shen, Yang
    TARGETED ONCOLOGY, 2023, 18 (06) : 869 - 883
  • [29] Efficacy and safety of niraparib as first-line maintenance treatment for patients with advanced ovarian cancer: Real-world data from a multicenter study in China
    Shen, Yang
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S317 - S317
  • [30] Efficacy, safety and prognostic factors analysis of first-line icotinib treatment in advanced non-small cell lung cancer patients with mutated EGFR
    Huang, Aimi
    Shen, Qing
    Yu, Xiaolu
    Wang, Huimin
    Shi, Chunlei
    Han, Baohui
    Gu, Aiqin
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : 600 - 608